A blog about chemistry, drug development, science, and technology
Seems even the Japanese are getting into the mega-meger trend. Now Mitsubishi Pharma will merge with Tanabe Seiyaku in a deal worth $4 billion.
Will not large by worldwide standards, this will create Japans 5th largest pharmaceutical company. Just as in the US, there is great pressure to control drug prices and they hope is this merger will make them more competitive world-wide.
Other Resources
Joint Press Conference on the Merger of Tanabe Seiyaku, Co., Ltd. and Mitsubishi Pharma Corporation (pdf)
Technorati Tags: Mitsubishi Pharma, pharma M&A, pharmaceutical deals, Tanabe Seiyaku
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.137 seconds